ID   ANGL4_HUMAN             Reviewed;         406 AA.
AC   Q9BY76; A8MY84; B4E089; D6W670; F5H0I2; Q53HQ6; Q53HU1; Q6UXN0;
AC   Q9HBV4; Q9NZU4; Q9Y5B3;
DT   08-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   08-NOV-2002, sequence version 2.
DT   10-MAY-2017, entry version 151.
DE   RecName: Full=Angiopoietin-related protein 4;
DE   AltName: Full=Angiopoietin-like protein 4;
DE   AltName: Full=Hepatic fibrinogen/angiopoietin-related protein;
DE            Short=HFARP;
DE   Flags: Precursor;
GN   Name=ANGPTL4; Synonyms=ARP4, HFARP, PGAR;
GN   ORFNames=PP1158, PSEC0166, UNQ171/PRO197;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY,
RP   SUBCELLULAR LOCATION, GLYCOSYLATION, AND VARIANT MET-266.
RX   PubMed=10698685; DOI=10.1042/bj3460603;
RA   Kim I., Kim H.-G., Kim H., Kim H.-H., Park S.K., Uhm C.-S., Lee Z.H.,
RA   Koh G.Y.;
RT   "Hepatic expression, synthesis and secretion of a novel
RT   fibrinogen/angiopoietin-related protein that prevents endothelial-cell
RT   apoptosis.";
RL   Biochem. J. 346:603-610(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND POSSIBLE FUNCTION.
RC   TISSUE=Aortic endothelium;
RX   PubMed=10866690; DOI=10.1128/MCB.20.14.5343-5349.2000;
RA   Yoon J.C., Chickering T.W., Rosen E.D., Dussault B., Qin Y.,
RA   Soukas A., Friedman J.M., Holmes W.E., Spiegelman B.M.;
RT   "Peroxisome proliferator-activated receptor gamma target gene encoding
RT   a novel angiopoietin-related protein associated with adipose
RT   differentiation.";
RL   Mol. Cell. Biol. 20:5343-5349(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=11953136;
RA   Zhu H., Li J., Qin W., Yang Y., He X., Wan D., Gu J.;
RT   "Cloning of a novel gene, ANGPTL4 and the functional study in
RT   angiogenesis.";
RL   Zhonghua Yi Xue Za Zhi 82:94-99(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.
RC   TISSUE=Placenta;
RX   PubMed=14583458;
RA   Ito Y., Oike Y., Yasunaga K., Hamada K., Miyata K., Matsumoto S.,
RA   Sugano S., Tanihara H., Masuho Y., Suda T.;
RT   "Inhibition of angiogenesis and vascular leakiness by angiopoietin-
RT   related protein 4.";
RL   Cancer Res. 63:6651-6657(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Hair follicle dermal papilla;
RA   Kim M.K., Kim Y.H., Seo J.M., Lee H.M., Chung H.J., Sohn M.Y.,
RA   Hwang S.Y., Im S.U., Jung E.J., Lee J.H., Kim J.C.;
RT   "A catalogue of genes in the human dermal papilla cells as identified
RT   by expressed sequence tags.";
RL   Submitted (MAY-1999) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   MET-266.
RC   TISSUE=Adipose tissue;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [12]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=12015030;
RA   Zhu H., Li J., Wan D., Yang Y., Qin W., Ge C., Yao M., Gu J.;
RT   "Expression and function of hepatocellular carcinoma-related gene
RT   pp1158.";
RL   Zhonghua Zhong Liu Za Zhi 24:123-125(2002).
RN   [13]
RP   ASSOCIATION WITH TGQTL, AND VARIANTS LEU-5; LYS-40; ILE-41; ARG-67;
RP   LEU-72; ARG-77; LYS-167; SER-174; GLN-190; LYS-196; CYS-230; ARG-233;
RP   VAL-237; THR-251; MET-266; GLN-278; MET-291; MET-293; VAL-296;
RP   SER-307; MET-308; CYS-336; GLU-338; CYS-349; SER-361; ARG-361; GLN-371
RP   AND TRP-384.
RX   PubMed=17322881; DOI=10.1038/ng1984;
RA   Romeo S., Pennacchio L.A., Fu Y., Boerwinkle E., Tybjaerg-Hansen A.,
RA   Hobbs H.H., Cohen J.C.;
RT   "Population-based resequencing of ANGPTL4 uncovers variations that
RT   reduce triglycerides and increase HDL.";
RL   Nat. Genet. 39:513-516(2007).
CC   -!- FUNCTION: Protein with hypoxia-induced expression in endothelial
CC       cells. May act as a regulator of angiogenesis and modulate
CC       tumorigenesis. Inhibits proliferation, migration, and tubule
CC       formation of endothelial cells and reduces vascular leakage. May
CC       exert a protective function on endothelial cells through an
CC       endocrine action. It is directly involved in regulating glucose
CC       homeostasis, lipid metabolism, and insulin sensitivity. In
CC       response to hypoxia, the unprocessed form of the protein
CC       accumulates in the subendothelial extracellular matrix (ECM). The
CC       matrix-associated and immobilized unprocessed form limits the
CC       formation of actin stress fibers and focal contacts in the
CC       adhering endothelial cells and inhibits their adhesion. It also
CC       decreases motility of endothelial cells and inhibits the sprouting
CC       and tube formation (By similarity). {ECO:0000250,
CC       ECO:0000269|PubMed:12015030, ECO:0000269|PubMed:14583458}.
CC   -!- SUBUNIT: Homooligomer. The homooligomer undergoes proteolytic
CC       processing to release its carboxyl fibrinogen-like domain, which
CC       circulates as a monomer. The homooligomer unprocessed form is able
CC       to interact with the extracellular matrix (By similarity).
CC       {ECO:0000250}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-2968146, EBI-2968146;
CC       P05556:ITGB1; NbExp=2; IntAct=EBI-2968146, EBI-703066;
CC       P18084:ITGB5; NbExp=3; IntAct=EBI-2968146, EBI-1223434;
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:10698685}.
CC       Secreted, extracellular space, extracellular matrix {ECO:0000250}.
CC       Note=The unprocessed form interacts with the extracellular matrix.
CC       This may constitute a dynamic reservoir, a regulatory mechanism of
CC       the bioavailability of ANGPTL4 (By similarity). {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9BY76-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BY76-2; Sequence=VSP_047045;
CC         Note=Gene prediction based on EST data.;
CC       Name=3;
CC         IsoId=Q9BY76-3; Sequence=VSP_055092;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed at high levels in the placenta,
CC       heart, liver, muscle, pancreas and lung but expressed poorly in
CC       the brain and kidney. {ECO:0000269|PubMed:10698685,
CC       ECO:0000269|PubMed:12015030}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:10698685}.
CC   -!- POLYMORPHISM: Genetic variations in ANGPTL4 are associated with
CC       low plasma triglyceride levels and define the plasma triglyceride
CC       level quantitative trait locus (TGQTL) [MIM:615881].
CC       {ECO:0000269|PubMed:17322881}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAQ88642.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF169312; AAF62868.1; -; mRNA.
DR   EMBL; AF202636; AAG22490.1; -; mRNA.
DR   EMBL; AB056477; BAB40692.1; -; mRNA.
DR   EMBL; AF153606; AAD41088.1; -; mRNA.
DR   EMBL; AY358275; AAQ88642.1; ALT_INIT; mRNA.
DR   EMBL; AK303269; BAG64351.1; -; mRNA.
DR   EMBL; AK222489; BAD96209.1; -; mRNA.
DR   EMBL; AK222524; BAD96244.1; -; mRNA.
DR   EMBL; AC136469; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471139; EAW68930.1; -; Genomic_DNA.
DR   EMBL; CH471139; EAW68931.1; -; Genomic_DNA.
DR   EMBL; BC023647; AAH23647.1; -; mRNA.
DR   CCDS; CCDS12200.1; -. [Q9BY76-1]
DR   CCDS; CCDS42493.1; -. [Q9BY76-2]
DR   RefSeq; NP_001034756.1; NM_001039667.2. [Q9BY76-2]
DR   RefSeq; NP_647475.1; NM_139314.2. [Q9BY76-1]
DR   UniGene; Hs.9613; -.
DR   ProteinModelPortal; Q9BY76; -.
DR   SMR; Q9BY76; -.
DR   BioGrid; 119316; 21.
DR   IntAct; Q9BY76; 15.
DR   STRING; 9606.ENSP00000301455; -.
DR   iPTMnet; Q9BY76; -.
DR   PhosphoSitePlus; Q9BY76; -.
DR   BioMuta; ANGPTL4; -.
DR   DMDM; 25008123; -.
DR   EPD; Q9BY76; -.
DR   MaxQB; Q9BY76; -.
DR   PaxDb; Q9BY76; -.
DR   PeptideAtlas; Q9BY76; -.
DR   PRIDE; Q9BY76; -.
DR   DNASU; 51129; -.
DR   Ensembl; ENST00000301455; ENSP00000301455; ENSG00000167772. [Q9BY76-1]
DR   Ensembl; ENST00000393962; ENSP00000377534; ENSG00000167772. [Q9BY76-2]
DR   Ensembl; ENST00000593998; ENSP00000472551; ENSG00000167772. [Q9BY76-1]
DR   GeneID; 51129; -.
DR   KEGG; hsa:51129; -.
DR   UCSC; uc002mjq.3; human. [Q9BY76-1]
DR   CTD; 51129; -.
DR   DisGeNET; 51129; -.
DR   GeneCards; ANGPTL4; -.
DR   HGNC; HGNC:16039; ANGPTL4.
DR   HPA; CAB033770; -.
DR   HPA; HPA007879; -.
DR   MalaCards; ANGPTL4; -.
DR   MIM; 605910; gene.
DR   MIM; 615881; phenotype.
DR   neXtProt; NX_Q9BY76; -.
DR   OpenTargets; ENSG00000167772; -.
DR   PharmGKB; PA24797; -.
DR   eggNOG; KOG2579; Eukaryota.
DR   eggNOG; ENOG410ZYS4; LUCA.
DR   GeneTree; ENSGT00830000128240; -.
DR   HOGENOM; HOG000015386; -.
DR   HOVERGEN; HBG001644; -.
DR   InParanoid; Q9BY76; -.
DR   KO; K08767; -.
DR   OMA; VDFNRPW; -.
DR   OrthoDB; EOG091G03M1; -.
DR   PhylomeDB; Q9BY76; -.
DR   TreeFam; TF329953; -.
DR   Reactome; R-HSA-174800; Chylomicron-mediated lipid transport.
DR   Reactome; R-HSA-1989781; PPARA activates gene expression.
DR   Reactome; R-HSA-381340; Transcriptional regulation of white adipocyte differentiation.
DR   ChiTaRS; ANGPTL4; human.
DR   GeneWiki; ANGPTL4; -.
DR   GenomeRNAi; 51129; -.
DR   PRO; PR:Q9BY76; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000167772; -.
DR   CleanEx; HS_ANGPTL4; -.
DR   ExpressionAtlas; Q9BY76; baseline and differential.
DR   Genevisible; Q9BY76; HS.
DR   GO; GO:0072562; C:blood microparticle; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IDA:MGI.
DR   GO; GO:0005578; C:proteinaceous extracellular matrix; IEA:UniProtKB-SubCell.
DR   GO; GO:0004857; F:enzyme inhibitor activity; ISS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0001525; P:angiogenesis; IEA:UniProtKB-KW.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB.
DR   GO; GO:2000352; P:negative regulation of endothelial cell apoptotic process; IEA:Ensembl.
DR   GO; GO:0051005; P:negative regulation of lipoprotein lipase activity; IDA:BHF-UCL.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; TAS:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:Ensembl.
DR   GO; GO:0001666; P:response to hypoxia; NAS:UniProtKB.
DR   GO; GO:0070328; P:triglyceride homeostasis; ISS:BHF-UCL.
DR   CDD; cd00087; FReD; 1.
DR   Gene3D; 3.90.215.10; -; 1.
DR   Gene3D; 4.10.530.10; -; 1.
DR   InterPro; IPR028793; ANGPTL4.
DR   InterPro; IPR014716; Fibrinogen_a/b/g_C_1.
DR   InterPro; IPR014715; Fibrinogen_a/b/g_C_2.
DR   InterPro; IPR002181; Fibrinogen_a/b/g_C_dom.
DR   InterPro; IPR020837; Fibrinogen_CS.
DR   PANTHER; PTHR19143:SF261; PTHR19143:SF261; 1.
DR   Pfam; PF00147; Fibrinogen_C; 1.
DR   SMART; SM00186; FBG; 1.
DR   SUPFAM; SSF56496; SSF56496; 1.
DR   PROSITE; PS00514; FIBRINOGEN_C_1; 1.
DR   PROSITE; PS51406; FIBRINOGEN_C_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Angiogenesis; Coiled coil; Complete proteome;
KW   Developmental protein; Differentiation; Disulfide bond;
KW   Extracellular matrix; Glycoprotein; Polymorphism; Reference proteome;
KW   Secreted; Signal.
FT   SIGNAL        1     25       {ECO:0000255}.
FT   CHAIN        26    406       Angiopoietin-related protein 4.
FT                                /FTId=PRO_0000009124.
FT   DOMAIN      179    401       Fibrinogen C-terminal.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00739}.
FT   COILED      100    143       {ECO:0000255}.
FT   CARBOHYD    177    177       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    188    216       {ECO:0000255|PROSITE-ProRule:PRU00739}.
FT   DISULFID    341    354       {ECO:0000255|PROSITE-ProRule:PRU00739}.
FT   VAR_SEQ       1    167       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055092.
FT   VAR_SEQ     183    221       RLPRDCQELFQVGERQSGLFEIQPQGSPPFLVNCKMTSD
FT                                -> H (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_047045.
FT   VARIANT       5      5       P -> L (in dbSNP:rs761583091).
FT                                {ECO:0000269|PubMed:17322881}.
FT                                /FTId=VAR_032642.
FT   VARIANT      40     40       E -> K (associated with lower plasma
FT                                levels of triglyceride and higher levels
FT                                of HDL cholesterol; dbSNP:rs116843064).
FT                                {ECO:0000269|PubMed:17322881}.
FT                                /FTId=VAR_032643.
FT   VARIANT      41     41       M -> I (in dbSNP:rs186754194).
FT                                {ECO:0000269|PubMed:17322881}.
FT                                /FTId=VAR_032644.
FT   VARIANT      67     67       S -> R (in dbSNP:rs538554190).
FT                                {ECO:0000269|PubMed:17322881}.
FT                                /FTId=VAR_032645.
FT   VARIANT      72     72       R -> L (in dbSNP:rs141831018).
FT                                {ECO:0000269|PubMed:17322881}.
FT                                /FTId=VAR_032646.
FT   VARIANT      77     77       G -> R (in dbSNP:rs568624939).
FT                                {ECO:0000269|PubMed:17322881}.
FT                                /FTId=VAR_032647.
FT   VARIANT     167    167       E -> K (in dbSNP:rs140640857).
FT                                {ECO:0000269|PubMed:17322881}.
FT                                /FTId=VAR_032648.
FT   VARIANT     174    174       P -> S. {ECO:0000269|PubMed:17322881}.
FT                                /FTId=VAR_032649.
FT   VARIANT     190    190       E -> Q (in dbSNP:rs77938377).
FT                                {ECO:0000269|PubMed:17322881}.
FT                                /FTId=VAR_032650.
FT   VARIANT     196    196       E -> K. {ECO:0000269|PubMed:17322881}.
FT                                /FTId=VAR_032651.
FT   VARIANT     230    230       R -> C (in dbSNP:rs201026877).
FT                                {ECO:0000269|PubMed:17322881}.
FT                                /FTId=VAR_032652.
FT   VARIANT     233    233       G -> R. {ECO:0000269|PubMed:17322881}.
FT                                /FTId=VAR_032653.
FT   VARIANT     237    237       F -> V (in dbSNP:rs768374046).
FT                                {ECO:0000269|PubMed:17322881}.
FT                                /FTId=VAR_032654.
FT   VARIANT     251    251       P -> T (in dbSNP:rs376328756).
FT                                {ECO:0000269|PubMed:17322881}.
FT                                /FTId=VAR_032655.
FT   VARIANT     266    266       T -> M (in dbSNP:rs1044250).
FT                                {ECO:0000269|PubMed:10698685,
FT                                ECO:0000269|PubMed:17322881,
FT                                ECO:0000269|Ref.8}.
FT                                /FTId=VAR_020428.
FT   VARIANT     278    278       R -> Q (in dbSNP:rs35061979).
FT                                {ECO:0000269|PubMed:17322881}.
FT                                /FTId=VAR_032656.
FT   VARIANT     291    291       V -> M (in dbSNP:rs150000287).
FT                                {ECO:0000269|PubMed:17322881}.
FT                                /FTId=VAR_032657.
FT   VARIANT     293    293       L -> M (in dbSNP:rs775667046).
FT                                {ECO:0000269|PubMed:17322881}.
FT                                /FTId=VAR_032658.
FT   VARIANT     296    296       E -> V. {ECO:0000269|PubMed:17322881}.
FT                                /FTId=VAR_032659.
FT   VARIANT     307    307       P -> S (in dbSNP:rs751249880).
FT                                {ECO:0000269|PubMed:17322881}.
FT                                /FTId=VAR_032660.
FT   VARIANT     308    308       V -> M (in dbSNP:rs139998264).
FT                                {ECO:0000269|PubMed:17322881}.
FT                                /FTId=VAR_032661.
FT   VARIANT     336    336       R -> C (in dbSNP:rs140744493).
FT                                {ECO:0000269|PubMed:17322881}.
FT                                /FTId=VAR_032662.
FT   VARIANT     338    338       D -> E (in dbSNP:rs780121474).
FT                                {ECO:0000269|PubMed:17322881}.
FT                                /FTId=VAR_032663.
FT   VARIANT     349    349       W -> C. {ECO:0000269|PubMed:17322881}.
FT                                /FTId=VAR_032664.
FT   VARIANT     361    361       G -> R (in dbSNP:rs755737249).
FT                                {ECO:0000269|PubMed:17322881}.
FT                                /FTId=VAR_032665.
FT   VARIANT     361    361       G -> S (in dbSNP:rs755737249).
FT                                {ECO:0000269|PubMed:17322881}.
FT                                /FTId=VAR_032666.
FT   VARIANT     371    371       R -> Q (in dbSNP:rs779488814).
FT                                {ECO:0000269|PubMed:17322881}.
FT                                /FTId=VAR_032667.
FT   VARIANT     384    384       R -> W (in dbSNP:rs146942305).
FT                                {ECO:0000269|PubMed:17322881}.
FT                                /FTId=VAR_032668.
FT   CONFLICT     55     71       LREHAERTRSQLSALER -> CANTGAHPQSAERAGA (in
FT                                Ref. 5; AAD41088). {ECO:0000305}.
FT   CONFLICT     60     60       E -> G (in Ref. 4; BAB40692).
FT                                {ECO:0000305}.
FT   CONFLICT    175    175       A -> P (in Ref. 1; AAF62868).
FT                                {ECO:0000305}.
FT   CONFLICT    237    237       F -> S (in Ref. 7; BAG64351).
FT                                {ECO:0000305}.
FT   CONFLICT    251    251       P -> S (in Ref. 8; BAD96209).
FT                                {ECO:0000305}.
FT   CONFLICT    270    270       N -> D (in Ref. 7 and 8). {ECO:0000305}.
FT   CONFLICT    277    277       L -> R (in Ref. 8; BAD96244).
FT                                {ECO:0000305}.
FT   CONFLICT    304    304       L -> F (in Ref. 1; AAF62868).
FT                                {ECO:0000305}.
FT   CONFLICT    363    363       Y -> H (in Ref. 8; BAD96209).
FT                                {ECO:0000305}.
FT   CONFLICT    389    389       P -> S (in Ref. 1; AAF62868).
FT                                {ECO:0000305}.
SQ   SEQUENCE   406 AA;  45214 MW;  219E56FEB3F602AF CRC64;
     MSGAPTAGAA LMLCAATAVL LSAQGGPVQS KSPRFASWDE MNVLAHGLLQ LGQGLREHAE
     RTRSQLSALE RRLSACGSAC QGTEGSTDLP LAPESRVDPE VLHSLQTQLK AQNSRIQQLF
     HKVAQQQRHL EKQHLRIQHL QSQFGLLDHK HLDHEVAKPA RRKRLPEMAQ PVDPAHNVSR
     LHRLPRDCQE LFQVGERQSG LFEIQPQGSP PFLVNCKMTS DGGWTVIQRR HDGSVDFNRP
     WEAYKAGFGD PHGEFWLGLE KVHSITGDRN SRLAVQLRDW DGNAELLQFS VHLGGEDTAY
     SLQLTAPVAG QLGATTVPPS GLSVPFSTWD QDHDLRRDKN CAKSLSGGWW FGTCSHSNLN
     GQYFRSIPQQ RQKLKKGIFW KTWRGRYYPL QATTMLIQPM AAEAAS
//
